| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f677b51d501b7faa84a3a5cba20c00a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665 |
| filingDate |
2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00fa065fa6c3d7590ac61a018e0730b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_004cf10ddba1db70ae12e263600a1d57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_500861e4447510968c3db0d648af4ea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25504f1e36be83116caf30ab388205d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd51680b9f31533d7552eaeb8522564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aae6a528f6cdd8ac47169fe5b2664a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc8edf5fbc4ffe970f7ea91d49e8990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_062aa4bb90d48026713f39b4260fca1f |
| publicationDate |
2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2015350400-A1 |
| titleOfInvention |
Phospholipid ether analogs as cancer-targeting drug vehicles |
| abstract |
The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells. The present invention is further directed to compositions comprising these therapeutic compounds and methods of treating cancer comprising administering these therapeutic compounds. A therapeutic compound comprising the formula A-B-D wherein: A is at least one compound of formula (I). |
| priorityDate |
2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |